COPD Clinical Trials in Philadelphia, PA

23 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry	—	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	<1 mi
Temple Health Chest Initiative (THCI 2.0)	—	Temple University	<1 mi
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening	—	Freenome Holdings Inc.	<1 mi
Feasibility of Semaglutide in Advanced Lung Disease	Phase 1/2	University of Pennsylvania	<1 mi
STRIVE Post-Market Registry Study	—	Olympus Corporation of the Americas	<1 mi
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease	Phase 2	AstraZeneca	<1 mi
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)	Phase 3	GlaxoSmithKline	<1 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype	Phase 3	Sanofi	<1 mi
SPIROMICS Study of Early COPD Progression (SOURCE)	—	University of Massachusetts, Worcester	<1 mi
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema	N/A	Pulmonx Corporation	<1 mi
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease	Phase 3	AstraZeneca	<1 mi
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital	N/A	Fisher and Paykel Healthcare	<1 mi
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3	N/A	Apreo Health, Inc.	<1 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)	Phase 3	AstraZeneca	<1 mi
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home	N/A	Temple University	<1 mi
Supporting Evidence-based Responses to Emotional Needs in Emphysema	N/A	University of Pennsylvania	<1 mi
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD	Phase 2	Johns Hopkins University	<1 mi
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD	N/A	Nuvaira, Inc.	<1 mi
COPD Exacerbation Follow Up	—	Viz.ai, Inc.	<1 mi
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment	Phase 2	Expedition Therapeutics, Inc	<1 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)	Phase 3	AstraZeneca	16 mi
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation	Phase 3	GlaxoSmithKline	24 mi
Multi-Center Clean Air Randomized Controlled Trial in COPD	Phase 3	JHSPH Center for Clinical Trials	49 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.